These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 32059974)
1. Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - Randomised controlled trial. Abdelhamid MI; Bari AA; Farid MI; Nour H Int J Surg; 2020 Mar; 75():174-178. PubMed ID: 32059974 [TBL] [Abstract][Full Text] [Related]
2. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer. Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072 [TBL] [Abstract][Full Text] [Related]
3. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial]. Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111 [TBL] [Abstract][Full Text] [Related]
4. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial. Klompenhouwer EG; Gobardhan PD; Beek MA; Voogd AC; Luiten EJ Trials; 2013 Apr; 14():111. PubMed ID: 23782712 [TBL] [Abstract][Full Text] [Related]
5. [Identification and preservation of arm lymphatics in axillary lymph node dissection to prevent arm lymphedema: a single center randomized controlled trial]. Yuan QQ; Wu GS; Hou JX; Zheng LW; Liao YQ; He YK Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):430-435. PubMed ID: 35615800 [No Abstract] [Full Text] [Related]
6. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer. Connor C; McGinness M; Mammen J; Ranallo L; Lafaver S; Klemp J; Fan F; Mahnken J Ann Surg Oncol; 2013 Oct; 20(10):3303-7. PubMed ID: 23975287 [TBL] [Abstract][Full Text] [Related]
7. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema. Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174 [TBL] [Abstract][Full Text] [Related]
8. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients? Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169 [TBL] [Abstract][Full Text] [Related]
9. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy? Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955 [TBL] [Abstract][Full Text] [Related]
10. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis. Wijaya WA; Peng J; He Y; Chen J; Cen Y Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404 [TBL] [Abstract][Full Text] [Related]
11. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162 [TBL] [Abstract][Full Text] [Related]
12. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review. Seyednejad N; Kuusk U; Wiseman SM Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187 [TBL] [Abstract][Full Text] [Related]
13. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection. Nos C; Clough KB; Bonnier P; Lasry S; Le Bouedec G; Flipo B; Classe JM; Missana MC; Doridot V; Giard S; Charitansky H; Charles-Nelson A; Bats AS; Ngo C Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634 [TBL] [Abstract][Full Text] [Related]
14. Lymph Node Positivity of Axillary Reverse Mapping Lymph Nodes at the Time of Axillary Lymph Node Dissection: Two-Site Prospective Trial. Benolken MM; McLaughlin S; Piltin M; Mrdutt M; Li Z; Jakub JW Ann Surg Oncol; 2023 Oct; 30(10):6042-6049. PubMed ID: 37466868 [TBL] [Abstract][Full Text] [Related]
15. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751 [TBL] [Abstract][Full Text] [Related]
16. Is axillary reverse mapping feasible in breast cancer patients? Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555 [TBL] [Abstract][Full Text] [Related]
17. Conservative axillary surgery is emerging in the surgical management of breast cancer. Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E; Haba Y Breast Cancer; 2023 Jan; 30(1):14-22. PubMed ID: 36342647 [TBL] [Abstract][Full Text] [Related]
18. Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population. Bhimani F; Feldman S; Cavalli A; Chen Y; Obaid L; Rachofsky C; Gupta A; Pastoriza J; Johnson K; McEvoy M Ann Surg Oncol; 2024 Sep; 31(9):5937-5946. PubMed ID: 38844631 [TBL] [Abstract][Full Text] [Related]
19. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Thompson M; Korourian S; Henry-Tillman R; Adkins L; Mumford S; Westbrook KC; Klimberg VS Ann Surg Oncol; 2007 Jun; 14(6):1890-5. PubMed ID: 17479341 [TBL] [Abstract][Full Text] [Related]
20. Axillary reverse mapping (ARM): where to go. Shao X; Sun B; Shen Y Breast Cancer; 2019 Jan; 26(1):1-10. PubMed ID: 29961238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]